Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Altimmune, Inc. stock logo
ALT
Altimmune
$3.34
+2.0%
$3.05
$2.56
$6.44
$648.72M0.184.29 million shs706,402 shs
Digital Turbine, Inc. stock logo
APPS
Digital Turbine
$11.68
-1.1%
$10.61
$2.74
$15.34
$1.42B2.873.98 million shs698,618 shs
The 10 Best High-Yield Dividend Stocks for 2026 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Altimmune, Inc. stock logo
ALT
Altimmune
0.00%-4.39%+11.22%+23.86%-10.16%
Digital Turbine, Inc. stock logo
APPS
Digital Turbine
0.00%+10.27%-5.06%+20.14%+155.63%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Altimmune, Inc. stock logo
ALT
Altimmune
$3.34
+2.0%
$3.05
$2.56
$6.44
$648.72M0.184.29 million shs706,402 shs
Digital Turbine, Inc. stock logo
APPS
Digital Turbine
$11.68
-1.1%
$10.61
$2.74
$15.34
$1.42B2.873.98 million shs698,618 shs
The 10 Best High-Yield Dividend Stocks for 2026 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Altimmune, Inc. stock logo
ALT
Altimmune
0.00%-4.39%+11.22%+23.86%-10.16%
Digital Turbine, Inc. stock logo
APPS
Digital Turbine
0.00%+10.27%-5.06%+20.14%+155.63%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Altimmune, Inc. stock logo
ALT
Altimmune
2.67
Moderate Buy$14.33329.79% Upside
Digital Turbine, Inc. stock logo
APPS
Digital Turbine
2.50
Moderate Buy$14.7526.28% Upside

Current Analyst Ratings Breakdown

Latest S247, ZOO, APPS, and ALT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/2/2026
Digital Turbine, Inc. stock logo
APPS
Digital Turbine
Reiterated RatingSell (E+)
8/6/2026
Digital Turbine, Inc. stock logo
APPS
Digital Turbine
Reiterated RatingBuy$17.50
8/5/2026
Digital Turbine, Inc. stock logo
APPS
Digital Turbine
Reiterated RatingBuy$18.00
8/5/2026
Digital Turbine, Inc. stock logo
APPS
Digital Turbine
Boost Price TargetBuy$15.00 ➝ $16.00
7/28/2026
Altimmune, Inc. stock logo
ALT
Altimmune
Reiterated RatingBuy
7/27/2026
Digital Turbine, Inc. stock logo
APPS
Digital Turbine
DowngradeStrong-BuyHold
7/21/2026
Digital Turbine, Inc. stock logo
APPS
Digital Turbine
Initiated CoverageBuy$15.00
7/21/2026
Digital Turbine, Inc. stock logo
APPS
Digital Turbine
Initiated CoverageBuy$11.50
7/21/2026
Digital Turbine, Inc. stock logo
APPS
Digital Turbine
UpgradeStrong-Buy
7/21/2026
Digital Turbine, Inc. stock logo
APPS
Digital Turbine
Initiated CoverageBuy$11.50
6/24/2026
Altimmune, Inc. stock logo
ALT
Altimmune
Reiterated RatingSell (D-)
(Data available from 9/14/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Altimmune, Inc. stock logo
ALT
Altimmune
$40K16,218.11N/AN/A$1.99 per share1.68
Digital Turbine, Inc. stock logo
APPS
Digital Turbine
$565.25M2.50$1.11 per share10.57$1.60 per share7.30
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Altimmune, Inc. stock logo
ALT
Altimmune
-$88.09M-$0.78N/AN/AN/A-214,860.98%-31.41%-26.96%11/5/2026 (Estimated)
Digital Turbine, Inc. stock logo
APPS
Digital Turbine
-$37.73M-$0.26N/A11.340.50-4.46%38.34%8.27%11/3/2026 (Estimated)

Latest S247, ZOO, APPS, and ALT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/11/2026Q2 2026
Altimmune, Inc. stock logo
ALT
Altimmune
-$0.1355-$0.12+$0.0155-$0.12$0.00 millionN/A
8/4/2026Q1 2027
Digital Turbine, Inc. stock logo
APPS
Digital Turbine
$0.14$0.19+$0.05-$0.09$149.98 million$165.98 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Altimmune, Inc. stock logo
ALT
Altimmune
N/AN/AN/AN/AN/A
Digital Turbine, Inc. stock logo
APPS
Digital Turbine
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Altimmune, Inc. stock logo
ALT
Altimmune
0.07
26.78
26.78
Digital Turbine, Inc. stock logo
APPS
Digital Turbine
1.80
1.20
1.20

Institutional Ownership

CompanyInstitutional Ownership
Altimmune, Inc. stock logo
ALT
Altimmune
78.05%
Digital Turbine, Inc. stock logo
APPS
Digital Turbine
63.66%

Insider Ownership

CompanyInsider Ownership
Altimmune, Inc. stock logo
ALT
Altimmune
1.60%
Digital Turbine, Inc. stock logo
APPS
Digital Turbine
6.00%
CompanyEmployeesShares OutstandingFree FloatOptionable
Altimmune, Inc. stock logo
ALT
Altimmune
57194.52 million191.41 millionOptionable
Digital Turbine, Inc. stock logo
APPS
Digital Turbine
620121.02 million113.76 millionOptionable

Recent News About These Companies

Digital Turbine (NASDAQ:APPS) Shares Up 4.4% - Here's Why
How Much Upside Can APP Stock's Growth Deliver?
APPS or SPOT: Which Is the Better Value Stock Right Now?

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Altimmune stock logo

Altimmune NASDAQ:ALT

$3.34 +0.07 (+1.99%)
As of 11:38 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide, a GLP-1/glucagon dual receptor agonist that is in Phase 2 trial for the treatment of obesity and metabolic dysfunction-associated steatohepatitis. It is also developing HepTcell, an immunotherapeutic product candidate, which is in Phase 2 clinical trial for patients chronically infected with the hepatitis B virus. The company was formerly known as Vaxin Inc. and changed its name to Altimmune, Inc. in September 2015. Altimmune, Inc. was founded in 1997 is headquartered in Gaithersburg, Maryland.

Digital Turbine stock logo

Digital Turbine NASDAQ:APPS

$11.72 -0.09 (-0.78%)
As of 11:38 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Digital Turbine, Inc., through its subsidiaries, operates a mobile growth platform for advertisers, publishers, carriers, and device original equipment manufacturers (OEMs). The company operates through two segments, On Device Solutions and App Growth Platform. Its application media platform delivers mobile applications to various publishers, carriers, OEMs, and devices; and content media platform offers news, weather, sports, and other content, as well as programmatic advertising and media content delivery services, and sponsored and editorial content media. The company also provides direct campaign management products, such as the DT DSP and DT Offer Wall; ad monetization solutions allow mobile app publishers and developers to monetize their monthly active users via display, native, and video advertising; brands and agencies runs mobile brand-awareness campaigns on the direct mobile app inventory; and app developers and other performance-focused advertisers execute mobile user acquisition campaigns for their apps and products. It operates in the United States, Canada, Europe, the Middle East, Africa, the Asia Pacific, China, Mexico, Central America, and South America. The company is headquartered in Austin, Texas.